Purchase Order 75F40123K00054
Award Date
6/29/23
Potential Completion Date
7/31/23
Potential Value
$25K
Federal Agency
Food and Drug Administration
Awardee
Orange Photonics, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
1195 - Miscellaneous Nuclear Ordnance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cincinnati, OH 45237, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Food and Drug Administration (FDA) awarded a $754,024.73 firm-fixed-price contract to S-3 Research LLC, a minority-owned, self-certified small disadvantaged business, to acquire data and services to better understand consumers and potential health risks from cannabis-derived products (CDPs). The contract, which does not have a set-aside designation, has a completion date of February 12, 2027. S-3 Research is a data science company that provides research-as-a-service solutions to federal...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $35,150.00 firm fixed-price purchase order contract to Purisys LLC, a for-profit limited liability company. The contract is for the delivery of 7-hydroxy-cannabidiol and 7-carboxy-cannabidiol, which are likely cannabinoid compounds. The contract has a total small business set-aside designation, indicating it was reserved for small business concerns. The period of performance runs from the award date of...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to R & D Enterprises, Inc., a for-profit small business. The contract, worth $95,980.00, is for the delivery of various scientific instruments and accessories used in bio-processing, research, and testing, such as mass spectrometers, thermal conductivity testers, rheometers, colorimeters, thermomechanical analyzers, and titration calorimeters. The contract has an...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,122,157.92 firm fixed price delivery order contract to Labstat International Inc., a foreign-owned for-profit organization, to conduct chemical, physical, and microbiological analyses of tobacco, e-cigarette, cannabis, and CBD products. This contract is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Labstat to provide tobacco laboratory services...
The U.S. Food and Drug Administration (FDA) awarded a $435,299.80 firm-fixed-price purchase order to Trajan Scientific Americas Inc., a foreign-owned small business manufacturer of scientific and medical devices, for the supply of a liquid chromatograph-gas chromatograph with flame ionization detector. This equipment will be used by the FDA for the analysis of mineral oil hydrocarbons (MOH) and sterols in fats and oils. The contract has a period of performance through September 10, 2025. This...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to IT1 Source LLC, a small business contractor. The contract is to provide a handheld Raman spectrometer system to support the FDA's efforts in interdicting opioid products, tainted dietary supplements, unapproved drugs, and COVID-19 related products. The contract has a ceiling value of $95,884.30 and was awarded under the Chief Information Officer Commodities and Solutions...
This is a $467,253.90 firm fixed price delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Labstat International Inc., a foreign-owned, for-profit organization. The contract is for the "Analysis of Matrix Specific HPHCS", which refers to the analysis of toxic constituents in tobacco, e-cigarette, cannabis, and CBD products to support the FDA's regulatory oversight. Labstat has been awarded multiple prior contracts by the...
The Food and Drug Administration (FDA) awarded a $128,000.00 firm fixed price purchase order to Brightfield Group LLC for an exploratory behavioral economics study. The award has a period of performance through June 30, 2025 and does not have a set-aside designation. Brightfield Group LLC is a for-profit partnership or limited liability partnership that provides data, research, and analytics services to federal agencies. The FDA has awarded multiple contracts and purchase orders to Brightfield...
The U.S. Food and Drug Administration (FDA), an agency of the Department of Health and Human Services (HHS), has awarded a firm fixed-price purchase order valued at $25,749.97 to Agilent Technologies Inc. for a CFSAN-2023-118815-BNE-GC-MSMS flow modulator. The contract period of performance runs from July 19, 2023 through September 29, 2024. As the prime contractor, Agilent Technologies Inc. will deliver the specified flow modulator to the FDA's Center for Food Safety and Applied Nutrition...
The Food and Drug Administration (FDA) awarded a $947,868.05 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for the delivery of a high-resolution ion mobility-high resolution mass spectrometer (HRIM-HRMS) system. This system will expand the FDA's analytical capabilities for ensuring the safety and efficacy of complex drugs like biologics, peptides, and oligonucleotides. The contract has a completion date of January 31, 2024 and includes training,...